What do systematic reviews say?

mg pregabalin · adults with moderate or severe neuropathic pain

Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with postherpetic neuralgia

Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy

Participant‐reported pain relief of 50% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy

Patient Global Impression of Change much or very much improved · adults with moderate or severe pain associated with painful diabetic neuropathy

PGIC very much improved · adults with moderate or severe pain associated with painful diabetic neuropathy

Lack of efficacy withdrawal · adults with moderate or severe pain associated with painful diabetic neuropathy

Participant‐reported pain relief of 50% or greater · adults with moderate or severe pain associated with postherpetic neuralgia

Somnolence · adults with moderate or severe pain associated with painful diabetic neuropathy

Dizziness · adults with moderate or severe pain associated with painful diabetic neuropathy

Withdrawals due to adverse events · adults with moderate or severe pain associated with painful diabetic neuropathy

Patient Global Impression of Change much or very much improved · adults with moderate or severe pain associated with postherpetic neuralgia

Lack of efficacy withdrawal · adults with moderate or severe pain associated with postherpetic neuralgia

Somnolence · adults with moderate or severe pain associated with postherpetic neuralgia

Dizziness · adults with moderate or severe pain associated with postherpetic neuralgia

Withdrawals due to adverse events · adults with moderate or severe pain associated with postherpetic neuralgia

Risk for at least one adverse event per patient · adults with moderate or severe neuropathic pain

Serious AE · adults with moderate or severe neuropathic pain